MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer Research

MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).

Triple negative breast cancer: Pitfalls and progress

TAS-119 is a Selective and Orally Active Aurora A Inhibitor

A novel small molecule STAT3 inhibitor SLSI-1216 suppresses

The novel STAT3 inhibitor WZ-2-033 causes regression of human

CFI-402257 is a Highly Selective and Orally Active Inhibitor of Mps1/TTK

Avitinib is an Irreversible, Mutant-Selective EGFR Inhibitor

PDF) STAT3 suppresses transcription of proapoptotic genes in

LY294002, a PI3K Inhibitor, is an Autophagy and Apoptosis Inducer

AC-73 is a Specific and Orally Active CD147 Dimerization Inhibitor

UZH1a is a Selective METTL3 Inhibitor

Biomedicines, Free Full-Text

Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast